抄録
Three-vial-treatment of Histaglobin was carried out on 38 patients with nasal allergy who had not found satisfactory relief with conventional Histaglobin one-vial-treatment. The clinical evaluation was performed in comparison with one-vial-treatment (36 patients).
Three-vial-treatment was significantly superior to one-vial-treatment in global judgement and improvement of some of the symptoms.
